(secondQuint)Comparison of ASCT and Conventional Chemotherapy in High Risk Waldenstrm Macroglobulinemia.

 WM patients with partial response after introduction chemotherapy will be recommended to adopt autologous stem cell transplantation or receive conventional chemotherapy (dependent on patient's choices).

 After transplantation or conventional chemotherapy, maintenance therapy with rituximab or thalidomide plus prednisone will be given for less than two years.

.

 Comparison of ASCT and Conventional Chemotherapy in High Risk Waldenstrm Macroglobulinemia@highlight

The purpose of this study is to evaluate whether autologous stem cell transplantation will improve the survival of patients with high-risk Waldenstrom macroglobulinemia, compared with conventional chemotherapy.

